Sometimes endometrial hyperplasia and early endometrial cancers can be treated with an intrauterine device (IUD) that contains a progestin called levonorgestrel.
Dec 21, 2020 · Cochrane authors investigated whether the levonorgestrel‐releasing intrauterine system (LNG‐IUS) can reduce the risk of endometrial polyps, abnormal thickening of the lining of the uterus and endometrial cancer in women taking tamoxifen following breast cancer
EH increases the risk of developing endometrial cancer, and can be described as without atypia (associated with a low risk of progression to atypia and
Levonorgestrel-releasing intrauterine system for endometrial hyperplasia
The levonorgestrel intrauterine device releases progestin, causing endometrial suppression and cervical mucus thickening, whereas the primary
Trusted evidence
Adult Medication
Endometrial Cancer Prevention with Levonorgestrel-Releasing Intrauterine System
There is no screening test for endometrial cancer right now